EVERYTHING ABOUT HEMGENIX

Range of suitable people: CDEC discussed the uncertainty in the number of patients with moderately severe to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific professionals consulted by CADTH indicated that some patients who will be categorized as owning gentle or reasonable disease can have a extreme bleeding phenot